The contribution of Raman spectroscopy to the analytical quality control of cytotoxic drugs in a hospital environment: eliminating the exposure risks for staff members and their work environment

Int J Pharm. 2014 Aug 15;470(1-2):70-6. doi: 10.1016/j.ijpharm.2014.04.064. Epub 2014 May 2.

Abstract

The purpose of the study was to perform a comparative analysis of the technical performance, respective costs and environmental effect of two invasive analytical methods (HPLC and UV/visible-FTIR) as compared to a new non-invasive analytical technique (Raman spectroscopy). Three pharmacotherapeutic models were used to compare the analytical performances of the three analytical techniques. Statistical inter-method correlation analysis was performed using non-parametric correlation rank tests. The study's economic component combined calculations relative to the depreciation of the equipment and the estimated cost of an AQC unit of work. In any case, analytical validation parameters of the three techniques were satisfactory, and strong correlations between the two spectroscopic techniques vs. HPLC were found. In addition, Raman spectroscopy was found to be superior as compared to the other techniques for numerous key criteria including a complete safety for operators and their occupational environment, a non-invasive procedure, no need for consumables, and a low operating cost. Finally, Raman spectroscopy appears superior for technical, economic and environmental objectives, as compared with the other invasive analytical methods.

Keywords: 5-Fluorouracil (PubChem CID: 3385); Analytical quality control; Cyclophosphamide (PubChem CID: 2907); Cytotoxic drugs; Doxorubicin (PubChem CID: 31,703); Epirubicin (PubChem CID: 341,867); Hospital environment; Ifosfamide (PubChem CID: 3690); Pharmacoeconomic considerations; Raman spectroscopy; Safety.

MeSH terms

  • Antineoplastic Agents / analysis*
  • Chromatography, High Pressure Liquid / economics
  • Cyclophosphamide / analysis
  • Doxorubicin / analysis
  • Epirubicin / analysis
  • Fluorouracil / analysis
  • Hospital Costs
  • Hospitals
  • Ifosfamide / analysis
  • Occupational Exposure / prevention & control*
  • Quality Control
  • Risk
  • Spectrophotometry, Ultraviolet / economics
  • Spectroscopy, Fourier Transform Infrared / economics
  • Spectrum Analysis, Raman
  • Workplace

Substances

  • Antineoplastic Agents
  • Epirubicin
  • Doxorubicin
  • Cyclophosphamide
  • Fluorouracil
  • Ifosfamide